Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuning Le

Showing results (71-80 of 179) with videos related to

Pageof 18
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 22, 2015
De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitorsXiuning Le, Neelam V Desai, Adnan Majid, et al.
Cancer Letters|March 22, 2023
Potent antitumor activity of ensartinib in MET exon 14 skipping-mutated non-small cell lung cancerYang Xia, Rui Jin, Miao Li, et al.
Lung Cancer (Amsterdam, Netherlands)|August 17, 2021
Lung adenocarcinoma with ERBB2 exon 20 insertions: Comutations and immunogenomic features related to chemoimmunotherapyPanwen Tian, Hao Zeng, Liyan Ji, et al.
Nature Reviews. Clinical Oncology|November 11, 2025
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approachesJing Zhao, Wanting Xu, Fei Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2021
Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLCSonia A Patel, Matthew H Herynk, Tina Cascone, et al.
NPJ Precision Oncology|February 5, 2026
Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinibMo Zhou, Yin Zhu, Xuqi Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2025
Advances in Targeting HER2 across Cancer Subtypes - A Pan-tumor ApproachTaiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav, et al.
Journal for Immunotherapy of Cancer|April 9, 2026
Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinomaAmaury Daste, Xiuning Le, Amani Makkouk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2024
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline MutationsKelsey Pan, Jennifer Owens, Yasir Elamin, et al.
Development (Cambridge, England)|April 26, 2013
A novel chemical screening strategy in zebrafish identifies common pathways in embryogenesis and rhabdomyosarcoma developmentXiuning Le, Emily K Pugach, Simone Hettmer, et al.
Pageof 18

Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
Lung Cancer (Amsterdam, Netherlands)|February 22, 2015
De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitorsXiuning Le, Neelam V Desai, Adnan Majid, et al.
Cancer Letters|March 22, 2023
Potent antitumor activity of ensartinib in MET exon 14 skipping-mutated non-small cell lung cancerYang Xia, Rui Jin, Miao Li, et al.
Lung Cancer (Amsterdam, Netherlands)|August 17, 2021
Lung adenocarcinoma with ERBB2 exon 20 insertions: Comutations and immunogenomic features related to chemoimmunotherapyPanwen Tian, Hao Zeng, Liyan Ji, et al.
Nature Reviews. Clinical Oncology|November 11, 2025
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approachesJing Zhao, Wanting Xu, Fei Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2021
Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLCSonia A Patel, Matthew H Herynk, Tina Cascone, et al.
NPJ Precision Oncology|February 5, 2026
Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinibMo Zhou, Yin Zhu, Xuqi Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2025
Advances in Targeting HER2 across Cancer Subtypes - A Pan-tumor ApproachTaiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav, et al.
Journal for Immunotherapy of Cancer|April 9, 2026
Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinomaAmaury Daste, Xiuning Le, Amani Makkouk, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2024
Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline MutationsKelsey Pan, Jennifer Owens, Yasir Elamin, et al.
Development (Cambridge, England)|April 26, 2013
A novel chemical screening strategy in zebrafish identifies common pathways in embryogenesis and rhabdomyosarcoma developmentXiuning Le, Emily K Pugach, Simone Hettmer, et al.
Pageof 18